Wecan Pharma shareholder Liu Zhongjiao pledges 6 million shares, accounting for 4.14% of total share capital for personal funding needs

robot
Abstract generation in progress

Zhejiang Weikang Pharmaceutical (Rights Protection) Co., Ltd. (Stock Code: 300878, Stock Name: Weikang Pharmaceutical) announced on March 18, 2026, that the company’s shareholder Liu Zhongjiao, holding more than 5% of shares, has pledged part of her shares.

The announcement shows that Liu Zhongjiao has pledged 6 million shares this time, accounting for 60.78% of her personal holdings in the company and 4.14% of the total share capital. These shares are freely tradable without restrictions. The pledge started on March 17, 2026, and will end upon the解除 of the pledge. The pledgee is Shenzhen Jiayin Pawn Co., Ltd., and the purpose of the pledge is for personal funding needs.

As of the date of this announcement, Liu Zhongjiao owns a total of 9,872,030 shares of Weikang Pharmaceutical, representing 6.82% of the company’s total share capital. After this pledge, her pledged shares total 6 million, accounting for 60.78% of her holdings and 4.14% of the total share capital. The remaining unpledged shares are 3,872,030, with no restrictions or freezes.

Shareholder Name
Number of Shares Held
Shareholding Ratio
Pledged Shares After This Pledge
Percentage of Her Holdings Pledged
Percentage of Total Share Capital
Unpledged Shares
Liu Zhongjiao
9,872,030
6.82%
6,000,000
60.78%
4.14%
3,872,030

The company states that this pledge of shareholder shares will not have a significant impact on the company’s production, operation, or governance. The pledge registration procedures have been completed. Relevant documents include the China Securities Depository and Clearing Corporation Limited’s securities pledge registration certificate and details of securities pledge and judicial freezes.

Click here to view the original announcement>>

Disclaimer: The market carries risks; investment should be cautious. This article is automatically generated by an AI model based on third-party databases and does not represent Sina Finance’s views. All information in this article is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for accuracy. If you have questions, contact biz@staff.sina.com.cn.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin